{"entity":{"type":"insider","cik":"0001254705","url":"/insider/0001254705","json_url":"/insider/0001254705.json","name":"BOHLIN GAREN G","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2021-05-10","last":"2026-05-13","span_basis":"filed_date"},"name_variants":[{"name":"BOHLIN GAREN G","source":"filing","n_filings":4,"first_seen":"2021-05-10","last_seen":"2026-05-13"}],"transactions":[{"id":6204500,"accession":"0001254705-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001254705-26-000002","line_url":"/filing/0001254705-26-000002#line-2","is_derivative":false,"issuer_cik":"0001254705","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001254705","owner_cik":"0001254705","owner_name":"BOHLIN GAREN G","owner_display_name":"BOHLIN GAREN G","owner_url":"/insider/0001254705","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8700.0,"shares_display":"8,700","price_per_share":37.1829,"price_display":"37.18","price_state":"stated","total_value":323491.23,"total_display":"323,491.23","total_whole":"323,491","shares_owned_after":62259.0,"shares_owned_after_display":"62,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-05-13","scope":"insider"},{"id":2860994,"accession":"0001062993-24-010536","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-24-010536","line_url":"/filing/0001062993-24-010536#line-2","is_derivative":false,"issuer_cik":"0001254705","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001254705","owner_cik":"0001254705","owner_name":"BOHLIN GAREN G","owner_display_name":"BOHLIN GAREN G","owner_url":"/insider/0001254705","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28985.0,"shares_display":"28,985","price_per_share":32.3033,"price_display":"32.30","price_state":"stated","total_value":936311.1505,"total_display":"936,311.15","total_whole":"936,311","shares_owned_after":44775.0,"shares_owned_after_display":"44,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-14","filed_date":"2024-05-16","scope":"insider"},{"id":8724256,"accession":"0000950170-23-047712","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-047712","line_url":"/filing/0000950170-23-047712#line-1","is_derivative":false,"issuer_cik":"0001254705","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001254705","owner_cik":"0001254705","owner_name":"BOHLIN GAREN G","owner_display_name":"BOHLIN GAREN G","owner_url":"/insider/0001254705","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":41140.0,"shares_display":"41,140","price_per_share":1.215,"price_display":"1.22","price_state":"stated","total_value":49985.1,"total_display":"49,985.10","total_whole":"49,985","shares_owned_after":45140.0,"shares_owned_after_display":"45,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-12","filed_date":"2023-09-12","scope":"insider"},{"id":5291646,"accession":"0001209191-21-031437","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-031437","line_url":"/filing/0001209191-21-031437#line-1","is_derivative":false,"issuer_cik":"0001254705","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001254705","owner_cik":"0001254705","owner_name":"BOHLIN GAREN G","owner_display_name":"BOHLIN GAREN G","owner_url":"/insider/0001254705","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":7.82,"price_display":"7.82","price_state":"stated","total_value":31280.0,"total_display":"31,280.00","total_whole":"31,280","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-06","filed_date":"2021-05-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001267565","name":"COLLEGIUM PHARMACEUTICAL, INC","url":"/issuer/0001267565","role":"Director","n_filings":2,"first_seen":"2024-05-16","last_seen":"2026-05-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001503802","name":"Karyopharm Therapeutics Inc.","url":"/issuer/0001503802","role":"Director","n_filings":2,"first_seen":"2021-05-10","last_seen":"2023-09-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001254705","retrieved_at":"2026-08-25T17:59:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}